The New England Journal of Medicine

May 11, 2025

Zepbound (tirzepatide) showed superior weight loss over Wegovy (semaglutide) in complete SURMOUNT-5 results published in The New England Journal of Medicine

May 19, 2020

NEJM Group Releases Covid-19 Rx for Interactive Learning

Dec 16, 2019

NEJM Group launches new journal, NEJM Catalyst Innovations in Care Delivery

Dec 04, 2019

Allergan Announces Positive Phase 3 ACHIEVE I Trial Results for Ubrogepant Published in The New England Journal of Medicine

Nov 04, 2019

Tencent and NEJM Yi Xue Qian Yan Host ME Summit to Promote Medical Science and Healthcare

Apr 17, 2019

United BioPharma Announces Publication of Breakthrough HIV Clinical Trial Data in the New England Journal of Medicine

Apr 04, 2019

NEJM Knowledge+ Awarded Grant and Launches Pain Management and Opioids Education CME Module

Jan 09, 2019

New England Journal of Medicine publishes positive results of the pivotal trial of Cablivi® (caplacizumab) for rare blood clotting disorder

Aug 14, 2018

Area9 Lyceum Recognized in New Adaptive Learning Survey Study from Researchers at Leading Health Organizations

Apr 18, 2018

Text Messaging Tool May Help Fight Opioid Epidemic

Dec 10, 2017

New Data for FDA-Approved CAR T Therapy Show Significant Remission Rates in 42% of Non-Hodgkin Lymphoma Patients

Jun 21, 2017

New England Journal of Medicine Publishes Results from Aetion Real-World Data Analysis